Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss

Eric Wooltorton, Wooltorton E
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005 · vol. 172(6) , pp. 746 · doi:10.1503/cmaj.050158 · PMID:15743913 · PMC552887 · W2124787758
article OA: gold CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

Reason for posting: Medroxyprogesterone acetate is an injectable agent widely used for contraception and the treatment of endometriosis. However, a warning was recently issued that patients taking this drug may experience a significant loss of bone mineral density.[1][1] The drug:

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (3)

Source provenance

europepmc
last seen: 2026-07-09T06:07:56.200469+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK